Stock Analiz

Immuneering Corp (IMRX) stock forecast and price target

Price $3.71 · data as of November 13, 2026

12-month price target

Average target$17.00
Upside / downside+358.2%
Analysts6
ConsensusStrong buy
Low $11.00Average $17.00High $30.00

Gold marker: average target · white marker: today’s price ($3.71)

Analyst ratings

Strong buy 2Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.26+1.0%$0
Next fiscal year
ends December 31, 2027
$-1.64−30.6%$0
Next quarter
ends December 31, 2026
$-0.41−126.2%$0
Quarter after
ends March 31, 2027
$-0.40−88.9%$0

Consensus of the analysts covering Immuneering, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Frequently asked questions

What is the Immuneering stock price target?

The average 12-month target from 6 analysts is $17.00, 358.2% above the current price of $3.71 Targets range from $11.00 to $30.00.

Is Immuneering a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Immuneering expected to earn?

Analysts expect EPS of $-1.26 for the fiscal year ending December 31, 2026 and $-1.64 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.